| RS1702008760 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy |
| RS1702008866 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related generalized epilepsy with febrile seizures plus, SCN2A-related generalized epilepsy with febrile seizures plus |
| RS1702009188 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS1702009644 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1702009872 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1702012175 |
SCN2A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1702015681 |
SCN2A
|
Health Risk |
Pathogenic |
West syndrome, West syndrome |
| RS1702025708 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1702039582 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1702072175 |
PGAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1702087452 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1702097862 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1702127048 |
PGAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1702151195 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702181550 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1702197212 |
HYAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1702200130 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1702201097 |
HYAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1702209367 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1702209747 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1702209886 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1702243883 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702337235 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702355636 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702376984 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702479861 |
TOP2B
|
Health Risk |
Conflicting classifications of pathogenicity |
B-cell immunodeficiency, distal limb anomalies |
| RS1702534679 |
PGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 42 |
| RS1702538795 |
PGAP1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1702579715 |
GAD1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 89, Developmental and epileptic encephalopathy 89 |
| RS1702611329 |
GAD1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 89, Developmental and epileptic encephalopathy 89 |
| RS17027133 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, LRBA-related disorder |
| RS1702741860 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702795017 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1702844873 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS17028450 |
TMPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1T, Primary dilated cardiomyopathy |
| RS1702866781 |
GAD1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 89, Developmental and epileptic encephalopathy 89 |
| RS1702887095 |
SUMF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1702889459 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Multiple sulfatase deficiency |
| RS1703021709 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1703025184 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1703086906 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type IV |
| RS1703089925 |
ROBO1
|
Health Risk |
Likely pathogenic |
Bilateral renal agenesis, Neurooculorenal syndrome |
| RS1703128782 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703133873 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1703133912 |
ZEB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703134531 |
ZEB2
|
Health Risk |
Likely pathogenic |
— |
| RS1703134890 |
ZEB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1703135134 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703164675 |
TTN
|
Health Risk |
Pathogenic |
Multiminicore myopathy, Multiminicore myopathy |
| RS1703168604 |
TYMS
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS17032279 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS1703231315 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703231612 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703232747 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703257054 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703257497 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703258379 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Spermatogenic failure 18 |
| RS1703258451 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1703265228 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703267358 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703269824 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703271038 |
ZEB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1703274205 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1703275164 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS1703276763 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mowat-Wilson syndrome |
| RS1703277223 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703278635 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703279692 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1703280349 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703280501 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703290664 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703292012 |
ZEB2
|
Health Risk |
Likely pathogenic |
— |
| RS1703292916 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mowat-Wilson syndrome |
| RS1703305546 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703305657 |
ZEB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1703306516 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS1703325248 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1703347063 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703347173 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1703370102 |
PGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 42 |
| RS1703393746 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1703415128 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1703436346 |
ZMYND10
|
Health Risk |
Likely pathogenic |
— |
| RS1703437679 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1703450134 |
PRKCD
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS1703516483 |
ZMYND10
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1703516836 |
ZMYND10
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1703520578 |
ZMYND10
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1703522059 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1703538852 |
DNAH1
|
Health Risk |
Likely pathogenic |
DNAH1-related disorder, DNAH1-related disorder |
| RS1703612751 |
NPRL2
|
Health Risk |
Pathogenic |
— |
| RS1703621639 |
NPRL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, familial focal |
| RS1703651493 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1703652698 |
NPRL2
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS17036536 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS1703664543 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1703670302 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS1703673227 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS1703692114 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1703726090 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |